Richard Saynor
About
Richard Saynor is from Basel Metropolitan Area. Richard is currently CEO at Sandoz, located in Basel, Switzerland. In Richard's previous role as a SVP Global Head, Classic and Established Medicines at GSK, Richard worked in Singapore until Jul 2019. Prior to joining GSK, Richard was a SVP Global Head, Established Products at GSK and held the position of SVP Global Head, Established Products at Singapore. Prior to that, Richard was a SVP, Classic Brands, Asia and Emerging Markets at GSK, based in Singapore from Sep 2010 to Apr 2013. Richard started working as Region Head Asia Pacific and Member of Sandoz Executive Committee at Sandoz in Singapore in Dec 2008. From Sep 2005 to Dec 2008, Richard was Head of Asia, Latam,Canada and Turkey. at Sandoz, based in Munich, Germany. Prior to that, Richard was a CEO at Generics [UK] ltd from Sep 2000 to Sep 2005. Richard started working as Marketing Manager at Norton Healthcare in Jan 1996.
Richard Saynor's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Richard Saynor's current jobs
Sandoz is the global leader in affordable medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 colleagues of 100 nationalities work together to ensure over one billion patients are reached by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 medicines addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. In 2026, Sandoz celebrates 20 years of pioneering biosimilars, 80 years of antibiotics manufacturing and 140 years of heritage. In 2025, Sandoz recorded net sales of USD 11.1 billion.
Richard Saynor's past jobs
Responsible for over £10bn of post-patent products covering number therapy areas (respiratory, allergy, Stiefel, Urology, anti-infectives, CNS). Lead a large cross functional team out of Singapore comprising of commercial and marketing centers of excellence in Mumbai, regional support structures, medical and regulatory functions. Sit on the Pharma Exec Committee and report to the Global Head of Pharmaceuticals.
Responsible for global portfolio of mature products with a turnover of £4bn. Build a global support unit to improve supply, medical and regulatory. Leverage commercial opportunities in market with particular focus on trade and channel. Propose strategic options to GSK: JV, Spin-out, Sell offs, etc., of assets.
I am responsible for GSK's Classic Brand Range (Non Patent) and introducing a branded Gx business in the Emerging Markets
Region consisted of all Asian markets (India, Japan, China, SEA, Australia). Grew region by cagr of 27%. Managed diverse region of 17 markets developing rapid growth strategies. Built new regional office with focus on SFE and productivity gains through talent management. Identified potential M&A targets and BD&I opportunities. Total regional headcount 2432, sales $450m. Built ‘originator minus’ concept for hyper-growth in China. Formed strategic partnerships in Japan and launched first biosimilar to this market.
Managed 65 markets, sales $1.3bn, 7000 headcount. Focus on market entry and rapid growth. Built strong commercial organizations with central support functions. Developed product launch plan for emerging markets leveraging Sandoz portfolio and pipeline. Restructured and rebuilt several key markets (Turkey, Australia, China).
CEO of G[UK]Ltd, Area Director for W.Europe, Africa and Middle East
Patent litigations. Demand planning. Marketing and sales operations